Correlation Between Oxford Nanopore and Lineage Cell
Can any of the company-specific risk be diversified away by investing in both Oxford Nanopore and Lineage Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oxford Nanopore and Lineage Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oxford Nanopore Technologies and Lineage Cell Therapeutics, you can compare the effects of market volatilities on Oxford Nanopore and Lineage Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oxford Nanopore with a short position of Lineage Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oxford Nanopore and Lineage Cell.
Diversification Opportunities for Oxford Nanopore and Lineage Cell
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Oxford and Lineage is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Oxford Nanopore Technologies and Lineage Cell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lineage Cell Therapeutics and Oxford Nanopore is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oxford Nanopore Technologies are associated (or correlated) with Lineage Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lineage Cell Therapeutics has no effect on the direction of Oxford Nanopore i.e., Oxford Nanopore and Lineage Cell go up and down completely randomly.
Pair Corralation between Oxford Nanopore and Lineage Cell
Assuming the 90 days horizon Oxford Nanopore Technologies is expected to generate 0.54 times more return on investment than Lineage Cell. However, Oxford Nanopore Technologies is 1.85 times less risky than Lineage Cell. It trades about -0.07 of its potential returns per unit of risk. Lineage Cell Therapeutics is currently generating about -0.29 per unit of risk. If you would invest 191.00 in Oxford Nanopore Technologies on August 27, 2024 and sell it today you would lose (14.00) from holding Oxford Nanopore Technologies or give up 7.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oxford Nanopore Technologies vs. Lineage Cell Therapeutics
Performance |
| Timeline |
| Oxford Nanopore Tech |
| Lineage Cell Therapeutics |
Oxford Nanopore and Lineage Cell Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oxford Nanopore and Lineage Cell
The main advantage of trading using opposite Oxford Nanopore and Lineage Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oxford Nanopore position performs unexpectedly, Lineage Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lineage Cell will offset losses from the drop in Lineage Cell's long position.The idea behind Oxford Nanopore Technologies and Lineage Cell Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Lineage Cell vs. MAIA Biotechnology | Lineage Cell vs. Armata Pharmaceuticals | Lineage Cell vs. Portage Biotech | Lineage Cell vs. Cadrenal Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |